Cleared Special

K223592 - Advanix Pancreatic Stent and NaviFlex R...

K223592 is the FDA 510(k) clearance for Advanix Pancreatic Stent and NaviFlex R... by Boston Scientific Corporation. It is a Class 2 Gastroenterology & Urology device (product code FGE) cleared through the Special 510(k) pathway after a 28-day FDA review.

K223592 · Boston Scientific Corporation · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
28d
Days
Class 2
Risk

K223592 is an FDA 510(k) clearance for the Advanix™ Pancreatic Stent and NaviFlex™ Rapid Exchange (RX) Pancreatic Delive.... Classified as Stents, Drains And Dilators For The Biliary Ducts (product code FGE), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on December 29, 2022 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5010 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K223592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 2022
Decision Date December 29, 2022
Days to Decision 28 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 130d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FGE Stents, Drains And Dilators For The Biliary Ducts
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5010
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FGE Stents, Drains And Dilators For The Biliary Ducts

All 298
Devices cleared under the same product code (FGE) and FDA review panel - the closest regulatory comparables to K223592.
WallFlex™ Biliary RX Stent System
K223469 · Boston Scientific Corporation · Jun 2023
Niti-S Biliary Speed D Stent
K223626 · Taewoong Medical Co., Ltd. · May 2023
MultiStage Balloon Dilatation Catheter
K222663 · Dongguan TT Medical, Inc. · Mar 2023
EndoGI S-Path Biliary Stent System
K222627 · Endo GI Medical · Sep 2022
Niti-S Biliary Slim M Stent
K221071 · Taewoong Medical Co., Ltd. · Jun 2022
Compass BDS Biliary Stent
K213946 · Cook Ireland, Ltd. · May 2022